Viewing Study NCT02204033


Ignite Creation Date: 2025-12-25 @ 2:51 AM
Ignite Modification Date: 2026-04-23 @ 7:18 PM
Study NCT ID: NCT02204033
Status: COMPLETED
Last Update Posted: 2014-07-30
First Post: 2014-07-29
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Dose Escalation Study With 99mTC - or 186 Re-labelled Humanised Monoclonal Antibody (hMAb) BIWA 4 in Patients With Head and Neck Cancer
Sponsor: Boehringer Ingelheim
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module